Illumina Signs Genotyping Services Agreement With Investigators At Boston University Medical Center.
Illumina Inc. announced that it has signed a commercial agreement with investigators at Boston University Medical Center to provide single nucleotide polymorphism (SNP) genotyping services for a large-scale research project on preterm birth. Under the terms of the agreement, Illumina will use its BeadArray(TM) technology to score a set of SNPs thought to be associated with preterm birth. Illumina will also design SNP assays for the SNP loci provided by the investigators.
